Inventor

FOLLMANN MARKUS

DE53 patents

⚠️ This page may combine multiple inventors who share the name “FOLLMANN MARKUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FOLLMANN MARKUS

Bayer Pharma AG

Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use

Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use

Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use

5-aminotetrahydroquinoline-2-carboxylic acids and their use

Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination with an inhibitor of neutral endopeptidase (NEP inhibitor) and/or an angiotensin AII antagonist and the use thereof

Trifluoromethyl-substituted fused pyrimidines and their use

5-aminotetrahydroquinoline-2-carboxylic acids and their use

3-aryl-substituted imidazo[1,2-A]pyridines and their use

5-aminotetrahydroquinoline-2-carboxylic acids and their use

Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use

Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereof

Substituted pyrazolo[1,5-A]-pyridine-3-carboxamides and use thereof

Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination with an inhibitor of neutral endopeptidase (NEP inhibitor) and/or an angiotensin AII antagonist and the use thereof

SGC stimulators in combination with additional treatment for the therapy of cystic fibrosis

Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use

3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines

Cyano-substituted imidazo[1,2-A]pyridinecarboxamides and their use

FOLLMANN MARKUS

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases

Bicyclic aza heterocycles, and use thereof

Substituted annellated pyrimidines and use thereof

Substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines and use thereof

Benzyl-substituted carbamates and use thereof

Fluoroalkyl-substituted pyrazolopyridines and use thereof

Ring-fused 4-aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases

Substituted imidazopyridines and the use thereof

Chlorothiophene-isoxazoles as inhibitors of coagulation factors Xa and thrombin

BAYER IP GMBH

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Substituted fused imidazoles and pyrazoles and use thereof

Substituted azabicycles and use thereof

Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase

Substituted annulated triazines and use thereof

MICHELS MARTIN

Fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof

Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof

Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof

Annellated 4-(indazolyl)-1,4-dihydropyridine derivatives and methods of use thereof

Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof

ADVERIO PHARMA GMBH

Substituted 5-flouro-1H-pyrazolopyridines and their use

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Substituted 5-fluoro-1H-pyrazolopyridines and their use

SANOFI SA

Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof

Chlorothiophene-amides as inhibitors of coagulation factors Xa and thrombin

Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments

HIRTH DIETRICH CLAUDIA

Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc)

SANOFI AVENTIS

Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases

BAYER AG

Substituted S-alaninate derivatives

RACKELMANN NILS

Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof

KALLUS CHRISTOPHER

Urea and sulfamide derivatives as inhibitors of TAFIa